To understand the tumor cell-autonomous mechanism underlying the tumor-promoting function of SMIMP and SMC1A, we further investigated the two targets cyclin-dependent kinase inhibitor (CDKN)1A and CDKN2B that have an established role in cell proliferation. Here, CDKN3 is linked to neoplasm.